[Form 4] Disc Medicine, Inc. Insider Trading Activity
Disc Medicine, Inc. (symbol: IRON) is the issuer of record for a Form 4 filing submitted to the SEC.
Rhea-AI Filing Summary
Disc Medicine, Inc. (symbol: IRON) is the issuer of record for a Form 4 filing submitted to the SEC.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and Sale: 27,136 shares ($679K approx. pre-tax spread)
Exercise and Sale
10 txns
Insider
Bitterman Kevin
Role
Director
Sold
27,136 shs ($1.90M)
Approx. gross sale proceeds
$1.90M
Approx. exercise cost
$1.22M
Approx. pre-tax spread
$679K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F5 | 7,136 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5 | 10,000 | $0.00 | $0.00 |
| Exercise | Stock Option (Right to Buy) F5 | 10,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,136 | $45.69 | $326K |
| Exercise | Common Stock | 10,000 | $38.85 | $389K |
| Exercise | Common Stock | 10,000 | $50.86 | $509K |
| Sale | Common Stock F1 | 27,136 | $70.11 | $1.90M |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
| holding | Common Stock F4 | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 contracts (Direct);
Common Stock — 0 shares (Direct);
Common Stock — 644,523 shares (Indirect, See footnote)
Footnotes (5)
- F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.10 to $70.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2. These shares are held by Atlas Venture Opportunity Fund I, L.P. ("Opportunity I"). The general partner of Opportunity I is Atlas Venture Associates Opportunity I, L.P. ("Associates I"). Atlas Venture Associates Opportunity I, LLC ("Associates I LLC") is the general partner of Associates I. The Reporting Person is a member of Associates I LLC and disclaims beneficial ownership of such securities held by Opportunity I, except to the extent of his pecuniary interest therein, if any.
- F3. These shares are held by Atlas Venture Opportunity Fund II, L.P. ("Opportunity II"). The general partner of Opportunity II is Atlas Venture Associates Opportunity II, L.P. ("Associates II"). Atlas Venture Associates Opportunity II, LLC ("Associates II LLC") is the general partner of Associates II. The Reporting Person is a member of Associates II LLC and disclaims beneficial ownership of such securities held by Opportunity II, except to the extent of his pecuniary interest therein, if any.
- F4. These shares are held by Atlas Venture Fund XII, L.P. ("Atlas XII"). The general partner of Atlas XII is Atlas Venture Associates XII, L.P. ("Associates XII"). Atlas Venture Associates XII, LLC ("Associates XII LLC") is the general partner of Associates XII. The Reporting Person is a member of Associates XII LLC and disclaims beneficial ownership of such securities held by Atlas XII, except to the extent of his pecuniary interest therein, if any.
- F5. Fully vested and exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
